Arch Oncology to Participate in Upcoming Conferences
BRISBANE, Calif. and ST. LOUIS, Feb. 16, 2021 (GLOBE NEWSWIRE) -- Arch Oncology, Inc., a clinical-stage immuno-oncology company focused on...
Month: February 2021
Enosi Life Sciences Appoints Drug Discovery Veteran Patrick Gray as its Newest Board Member
SAN DIEGO, Feb. 16, 2021 (GLOBE NEWSWIRE) -- Enosi Life Sciences, a drug research and development company focused on providing...
2020 Canadian Pet Population Figures Released
A part of the family The COVID-19 pandemic has highlighted the special relationship we have with our pets; they are...
BioSig Appoints Brenda Castrodad to Lead Human Resources
Seasoned medtech executive to scale up the Company’s organizational development upon the increase in demand for the evaluative installations of...
HealthyWomen and Myovant Sciences Launch “Voices of Periods” to Fight Menstrual Stigma
Six women reflect on their period experiences and journeys to self-advocacy in new video series Video stories and additional information...
Enlivex Announces Issuance of New U.S. Patent Covering Methods of Treating Gout, Inflammatory Bowel Disease, Crohn’s Disease, Ulcerative Colitis and GvHD Using Allocetra Immunotherapy
Nes-Ziona, Israel, Feb. 16, 2021 (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd., (Nasdaq: ENLV, the “Company”), a clinical-stage macrophage reprogramming immunotherapy...
Resonant Appoints New Technical Thought Leaders to Advisory Board and Creates Technical Committee
Technical Committee Formed to Advance Adoption and Development of XBAR® Technologies in 5G, Wi-Fi and Other Growth Markets Company Appoints...
Radius Health to Announce Fourth Quarter 2020 Financial Results, Host Conference Call and Live Webcast on Thursday, February 25, 2021
BOSTON, Feb. 16, 2021 (GLOBE NEWSWIRE) -- Radius Health (Nasdaq: RDUS) announced today that it will release its fourth quarter financial...
Nemaura Medical Reports Financial Results for Third Quarter of Fiscal Year 2021 and Provides Corporate Update
Loughborough, England, Feb. 16, 2021 (GLOBE NEWSWIRE) -- Nemaura Medical Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology...
Indus Holdings, Inc. to Report 4th Quarter and Fiscal Year 2020 Financial and Operational Results
Cannabis industry leader to host conference call on March 2, 2021 SALINAS, Calif., Feb. 16, 2021 (GLOBE NEWSWIRE) -- Indus...
Vericel to Participate in the BTIG Virtual MedTech Digital Health, Life Science & Diagnostic Tools Conference on February 18, 2021
CAMBRIDGE, Mass., Feb. 16, 2021 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine...
Artelo Biosciences Announces Appointment of Andrew Yates, Ph.D. as Senior Vice President and Chief Scientific Officer
LA JOLLA, Calif., Feb. 16, 2021 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (NASDAQ: ARTL), a clinical stage biopharmaceutical company focused...
Outlook Therapeutics Reports Financial Results for First Quarter Fiscal Year 2021 and Provides Corporate Update
Topline data from pivotal Phase 3 safety and efficacy study (NORSE TWO) on target to report in Q3 2021Topline data...
Eyenovia to Host Key Opinion Leader Webinar on Presbyopia
The webinar, “Presbyopia in Focus: Unlocking One of the Biggest Market Opportunities in Ophthalmology,” is scheduled for Monday, February 22,...
PMV Pharma Appoints p53 Pioneer Dr. Guillermina Lozano to Scientific Advisory Board
CRANBURY, N.J., Feb. 16, 2021 (GLOBE NEWSWIRE) -- PMV Pharmaceuticals, Inc. (Nasdaq: PMVP), a precision oncology company pioneering the discovery...
Accolade to Participate in Upcoming Investor Conferences
SEATTLE, Feb. 16, 2021 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), which provides personalized, technology-enabled solutions that help people better...
Beyond Air® Receives Grant for Up to $2.17 million from the Cystic Fibrosis Foundation to Advance the Clinical Development of Inhaled Nitric Oxide to Treat Nontuberculous Mycobacteria Pulmonary Disease
Award will help fund the development of high concentration nitric oxide (NO) for Nontuberculous Mycobacteria (NTM) pulmonary disease, which disproportionately...
AGTC to Present at the 4th Annual Gene Therapy for Rare Disorders Digital Event, February 22-25, 2021
-AGTC executives will address critical success factors in gene therapy manufacturing and the value of the patient perspective in gene...
electroCore Announces 510(k) Clearance of gammaCore™ Non-Invasive Vagus Nerve Stimulation (nVNS) to Treat Adolescent Migraine
FDA clearance expands gammaCore label to include the acute and preventive treatment of migraine in adolescents 12 to 17 years...
Onconova Therapeutics to Present Corporate Update at the 2021 BIO CEO & Investor Digital Conference
NEWTOWN, Pa., Feb. 16, 2021 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX) (“Onconova”), a biopharmaceutical company focused on discovering...